Serial Number: 85182779

Word Mark: T

Goods and Services: IC 005. US 006 018 044 046 051 052. G & S: pharmaceuticals, namely, treatment for central nervous disorders, cancer, hematological disorders, endocrine disorders, metabolic disorders, inflammatory disorders, gastrointestinal disorders, liver disease, heart disorders, lung and bronchial disease, blood cardiovascular disease, circulatory system disease, intestinal disorders, bone disease, autoimmune disorders and disorders of the immune systems, infectious disease and enzyme deficiency disease; implantable delivery systems comprised of sustainable release drugs for treatment for central nervous disorders and other serious and life-threatening diseases, cancer, hematological disorders, endocrine disorders, metabolic disorders, inflammatory disorders, gastrointestinal disorders, liver disease, heart disorders, lung and bronchial disease, blood cardiovascular disease, circulatory system disease, intestinal disorders, bone disease, autoimmune disorders and disorders of the immune systems, infectious disease and enzyme deficiency disease

Mark Drawing Code: (3) DESIGN PLUS WORDS, LETTERS, AND/OR NUMBERS

Design Search Code: 26.01.21 - Circles that are totally or partially shaded.
26.05.21 - Triangles that are completely or partially shaded
26.09.03 - Incomplete squares; Squares, incomplete

Filing Date: 11/22/2010

Current Basis: 1B

Original Filing Basis: 1B

Owner: (APPLICANT) Titan Pharmaceuticals, Inc. CORPORATION DELAWARE 400 Oyster Point Boulevard, Suite 505 South San Francisco CALIFORNIA 940801921

Attorney of Record: Rosemary S. Tarlton

Description of Mark: Color is not claimed as a feature of the mark. The mark consists of a stylized letter "T", a triangle with a dot in the middle and an incomplete square.

Type of Mark: TRADEMARK

Register: PRINCIPAL

Live/Dead Indicator: LIVE

SiteNo: 1594